Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy

ABSTRACT Background Outcomes for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that have progression after treatment with hypomethylating agent (HMA) and venetoclax (VEN) are poor. However, data for chemotherapy and VEN (C+VEN) therapy after prior treatment with HMA+VE...

書目詳細資料
發表在:	eJHaem
Main Authors:	Rafael Madero‐Marroquin, Joseph Cannova, Emily Dworkin, Austin Wesevich, Gregory W. Roloff, Caner Saygin, Mariam T. Nawas, Adam S. DuVall, Satyajit Kosuri, Michael J. Thirman, Olatoyosi Odenike, Wendy Stock, Richard A. Larson, Michael W. Drazer, Anand A. Patel
格式:	Article
語言:	英语
出版:	Wiley 2025-06-01
主題:	acute leukemia AML chemotherapy MDS myeloid leukemia
在線閱讀:	https://doi.org/10.1002/jha2.70078

相似書籍

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia
由: Ian M. Bouligny, et al.
出版: (2023-05-01)

Outcomes With Venetoclax 50 mg, Hypomethylating Agents, and Voriconazole or Posaconazole in Acute Myeloid Leukemia
由: Kendall Diebold, et al.
出版: (2025-06-01)

Older Jehovah’s Witnesses with Acute Myeloid Leukemia: Hypomethylating Agents and Venetoclax as a Transfusion-Sparing Approach
由: Aditi Sharma, et al.
出版: (2025-06-01)

Factors affecting response and resistance to venetoclax in acute myeloid leukemia
由: Michael D. Diamantidis
出版: (2025-09-01)

Oridonin Synergistically Enhances the Pro-Apoptotic Effect of Venetoclax on Acute Myeloid Leukemia Cells by Inhibiting AKT Signaling
由: Lin Chen, et al.
出版: (2023-09-01)

Venetoclax – The game-changer in hematology
由: Tanmoy Kumar Mandal, et al.
出版: (2020-01-01)

Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy
由: Timothy E. O’Connor, et al.
出版: (2023-05-01)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
由: Jacob Shreve, et al.
出版: (2020-04-01)

CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia
由: Lixiazi He, et al.
出版: (2022-03-01)

VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (literature review)
由: T. E. Byalik
出版: (2018-07-01)

In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia
由: Alexia Vereertbrugghen, et al.
出版: (2021-07-01)

An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
由: Stuart L. Goldberg, et al.
出版: (2014-01-01)

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
由: Xing-yu Cao, et al.
出版: (2023-12-01)

The sweet symphony of N-glycans in myeloid malignancies
由: Javier Sanmartín-Martínez, et al.
出版: (2024-07-01)

Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
由: Xi Xu, et al.
出版: (2023-10-01)

Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy
由: Guanghao Liang, et al.
出版: (2023-08-01)

Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
由: Ranjit Kumar Sahoo, et al.
出版: (2013-01-01)

Successful experience of venetoclax in the treatment of refractory primary plasma cell leukemia
由: I. V. Cherkashina, et al.
出版: (2025-03-01)

Liquid biopsies and minimal residual disease in myeloid malignancies
由: Sabine Allam, et al.
出版: (2023-05-01)

IDH2-mutated near ETP-ALL with aggressive leukemia cutis and brisk response to venetoclax and decitabine
由: Poorva Vaidya, et al.
出版: (2024-01-01)

CD58 expression does not impact response to inotuzumab ozogamicin in patients with B‐cell acute lymphoblastic leukemia
由: Rafael Madero‐Marroquin, et al.
出版: (2025-02-01)

Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes
由: Kevin Yao, et al.
出版: (2023-03-01)

CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy
由: Mustafa Nissar Bankur, et al.
出版: (2022-06-01)

LEUKEMIA CUTIS
由: Leonel Barbosa Gonçalves
出版: (2015-03-01)

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study
由: Ines Zugasti, et al.
出版: (2025-04-01)

Venetoclax: A Novel Therapeutic Agent for CLL with CNS Involvement
由: Nishika Karbhari, et al.
出版: (2022-03-01)

The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation
由: Zhipeng Li, et al.
出版: (2024-04-01)

The roles of non-coding RNAs (ncRNAs) in the function of leukemic stem cells (LSCs): a comprehensive review
由: Mehran Sharifi, et al.
出版: (2025-08-01)

HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Leukemia
由: Farideh Khosravi, et al.
出版: (2007-09-01)

Research progress of anti-apoptotic inhibitor venetoclax in treatment of myeloid leukemia
由: XIANG Caixia, HUANG Bintao, HAO Jian
出版: (2023-05-01)

Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients
由: Isacco Ferrarini, et al.
出版: (2022-04-01)

Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia
由: Farinoosh Dadrass, et al.
出版: (2022-08-01)

A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
由: Roula Antoine Farah
出版: (2014-12-01)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
由: Christoforos K. Vaxevanis, et al.
出版: (2023-12-01)

Quizartinib Therapy for FLT3-positive Acute Myeloid Leukaemia
由: Amna Faheem Mufti, et al.
出版: (2024-10-01)

Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines: A Correlation with the Differentiation Status
由: Hassan Dakik, et al.
出版: (2021-03-01)

Hemophagocytosis by acute myeloid leukemia blasts associated to poor clinical outcomes
由: Zangbéwendé Guy Ouedraogo, et al.
出版: (2022-05-01)

Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes
由: Stein Ove Døskeland, et al.
出版: (2010-10-01)

De-novo acute myeloid leukemia in a BRCA positive female with locally treated ductal carcinoma In Situ
由: Edward Nabrinsky, MD, et al.
出版: (2021-01-01)

Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia
由: Mariarita Sciumè, et al.
出版: (2023-03-01)